ID: ALA5281014

Max Phase: Preclinical

Molecular Formula: C15H20O5

Molecular Weight: 280.32

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H]1C[C@H]2OC(=O)[C@@H](C)[C@H]2[C@H](O)[C@]2(C)C(=O)C3OC3[C@@H]12

Standard InChI:  InChI=1S/C15H20O5/c1-5-4-7-8(6(2)14(18)19-7)12(16)15(3)9(5)10-11(20-10)13(15)17/h5-12,16H,4H2,1-3H3/t5-,6+,7-,8-,9-,10?,11?,12+,15-/m1/s1

Standard InChI Key:  YKAPJDFMXLHZTC-BRMBMJFOSA-N

Molfile:  

 
     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
   -0.9451    0.6223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2970    1.1329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5073    0.9489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8661    0.2084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5079   -0.5413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2970   -0.7253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9451   -0.2102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7055    0.0865    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8495   -0.7117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1125   -1.1047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5108   -1.5235    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7565   -0.4626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2315    0.1968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7350    0.8705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9703   -1.2608    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5651    0.9626    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5651   -1.1249    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1125   -1.9311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5108    1.9311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1589    1.4205    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9451   -1.0365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4505    0.7927    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.5079   -1.3677    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  7  1  0
  7  6  1  0
  4  8  1  0
  8  9  1  0
 10  9  1  0
  5 10  1  0
  6 11  1  6
  7 12  1  0
 12 13  1  0
 14 13  1  0
  1 14  1  0
 12 15  2  0
 13 16  1  0
 14 16  1  0
  9 17  2  0
 10 18  1  1
  2 19  1  6
  1 20  1  6
  7 21  1  1
  4 22  1  6
  5 23  1  6
M  END

Alternative Forms

  1. Parent:

    ALA5281014

    ---

Associated Targets(Human)

HEp-2 (3859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 280.32Molecular Weight (Monoisotopic): 280.1311AlogP: 0.54#Rotatable Bonds:
Polar Surface Area: 76.13Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 1.00CX LogD: 1.00
Aromatic Rings: Heavy Atoms: 20QED Weighted: 0.52Np Likeness Score: 3.07

References

1. Gomes AR, Varela CL, Tavares-da-Silva EJ, Roleira FMF..  (2020)  Epoxide containing molecules: A good or a bad drug design approach.,  201  [PMID:32526552] [10.1016/j.ejmech.2020.112327]

Source